[HTML][HTML] Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review

M Albratty, HA Alhazmi - Arabian Journal of Chemistry, 2022 - Elsevier
Pyridines and pyrimidines are the class of heterocyclic nitrogenous compounds having
plethora of applications in anticancer drug development. These synthetic sources serve as …

A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential

J Basha, NM Goudgaon - Journal of Molecular Structure, 2021 - Elsevier
Pyrimidines are nitrogen-containing heterocycles known for anticancer, anti-HIV, antifungal,
and antibacterial activities. Pyrimidines, compounds bearing this heterocycle, are common …

New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in …

H Elkady, A Elwan, HA El-Mahdy… - Journal of enzyme …, 2022 - Taylor & Francis
A new series of benzoxazole derivatives were designed and synthesised to have the main
essential pharmacophoric features of VEGFR-2 inhibitors. Cytotoxic activities were …

[HTML][HTML] A multistage in silico study of natural potential inhibitors targeting SARS-CoV-2 main protease

EB Elkaeed, IH Eissa, H Elkady, A Abdelalim… - International Journal of …, 2022 - mdpi.com
Among a group of 310 natural antiviral natural metabolites, our team identified three
compounds as the most potent natural inhibitors against the SARS-CoV-2 main protease …

New quinoxaline-2 (1 H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations

RG Yousef, HM Sakr, IH Eissa, ABM Mehany… - New Journal of …, 2021 - pubs.rsc.org
Eleven new quinoxaline derivatives were designed and synthesized as modified VEGFR-2
inhibitors of our previous work. The synthesized compounds were tested against three …

[HTML][HTML] New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies

MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah… - RSC …, 2021 - pubs.rsc.org
A new series of 3-methylquinoxaline-based derivatives having the same essential
pharmacophoric features as VEGFR-2 inhibitors have been synthesized and evaluated for …

New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies

IMM Othman, ZM Alamshany, NY Tashkandi… - Bioorganic …, 2021 - Elsevier
This study was focused on the synthesis of new pyrimidines 4a, b, 5a, b and pyrazoles 6a, b
as ATP mimicking tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR) …

New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis

NA Alsaif, MA Dahab, MM Alanazi, AJ Obaidullah… - Bioorganic …, 2021 - Elsevier
Abstract New series of [1, 2, 4] triazolo [4, 3-a] quinoxalin-4 (5H)-one and [1, 2, 4] triazolo [4,
3-a] quinoxaline derivatives have been designed, synthesized, and biologically assessed for …

New bis ([1, 2, 4] triazolo)[4, 3-a: 3′, 4′-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer …

MM Alanazi, HA Mahdy, NA Alsaif, AJ Obaidullah… - Bioorganic …, 2021 - Elsevier
A new series of bis ([1, 2, 4] triazolo)[4, 3-a: 3′, 4′-c] quinoxaline derivatives were
designed and synthesized to have the main essential pharmacophoric features of VEGFR-2 …

Discovery of new quinoxaline-2 (1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation

K El-Adl, HM Sakr, RG Yousef, ABM Mehany… - Bioorganic …, 2021 - Elsevier
VEGF/VEGFR2 pathway is the crucial therapeutic target in the treatment of cancer. So that, a
new series of quinoxaline-2 (1H)-one derivatives were designed and synthesized. The …